Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bifidobacterium infantis (1 trial)
Celiac Disease (Phase 2)
Trials (1 total)
Trial APIs (1 total)